Background: Breast cancer aetiology may differ by estrogen receptor (ER) status. Associations of alcohol and folate intakes with risk of breast cancer defined by ER status were examined in pooled analyses of the primary data from 20 cohorts. Methods: During a maximum of 6-18 years of follow-up of 1 089 273 women, 21 624 ERþ and 5113 ERÀ breast cancers were identified. Study-specific multivariable relative risks (RRs) were calculated using Cox proportional hazards regression models and then combined using a random-effects model. Results: Alcohol consumption was positively associated with risk of ERþ and ERÀ breast cancer. The pooled multivariable RRs (95% confidence intervals) comparing ! 30 g/d with 0 g/day of alcohol consumption were 1.35 (1.23-1.48) for ERþ and 1.28 (1.10-1.49) for ERÀ breast cancer (P trend 0.001; P common-effects by ER status: 0.57). Associations were similar for alcohol intake from beer, wine and liquor. The associations with alcohol intake did not vary significantly by total (from foods and supplements) folate intake (P interaction ! 0.26). Dietary (from foods only) and total folate intakes were not associated with risk of overall, ERþ and ERÀ breast cancer; pooled multivariable RRs ranged from 0.98 to 1.02 comparing extreme quintiles. Following-up US studies through only the period before mandatory folic acid fortification did not change the results. The alcohol and folate associations did not vary by tumour subtypes defined by progesterone receptor status. Conclusions: Alcohol consumption was positively associated with risk of both ERþ and ERÀ breast cancer, even among women with high folate intake. Folate intake was not associated with breast cancer risk.
Introduction
Estrogen receptor negative (ER-) breast cancer is a less common but more aggressive breast cancer subtype than ER positive (ERþ) breast cancer. 1 Little is known about the aetiology of ERÀ breast cancer because most studies are limited by the relatively small number of ERÀ breast cancer cases. Although alcohol consumption is a convincing cause of breast cancer, 2 the evidence from cohort studies for an association between alcohol consumption and ERÀ breast cancer risk is limited. A recent meta-analysis of 19 studies (3 cohort studies and 16 case-control studies) reported that the summary relative risk (RR) for ERÀ tumours, comparing the highest with lowest alcohol intake category, was 1.14 [95% confidence interval (CI): 1.03- 1.26 ] for all studies and 1.21 (95% CI: 0.84-1.74) for three cohort studies. 3 Of six subsequently published cohort studies, [4] [5] [6] [7] [8] [9] only the Multiethnic Cohort Study showed a statistically significant positive association between alcohol consumption and ERÀ breast cancer risk. 8 Furthermore, alcohol-disrupted folate metabolism increases DNA instability and aberrant DNA methylation, which alters epigenetic regulation of gene expression; 10, 11 previously, two prospective cohort studies 12, 13 found that the increased risk of ERÀ breast cancer for drinkers was attenuated among those with high folate intake.
To address the limited number of ERÀ cases in most individual studies, we expanded our initial analyses 14 of alcohol consumption and overall breast cancer risk and evaluated the association between alcohol intake and risk of breast cancer defined by ER status. These analyses include 14 additional cohort studies and longer follow-up for studies in the original analyses, resulting in an additional 33 590 cases. We also examined whether associations with alcohol consumption varied by folate intake. In secondary analyses, we examined associations with tumours classified by progesterone receptor (PR) status.
Methods

Study population
This analysis includes 20 prospective cohort studies (Table 1) within the Pooling Project of Prospective Studies of Diet and Cancer. 15 Each study met the following inclusion criteria: (i) at least one publication on a diet and cancer association; (ii) ascertainment of at least 25 incident ERÀ or PRÀ breast cancer cases; (iii) long-term diet assessment; (iv) validation of diet assessment; and (v) assessment of alcohol or dietary folate intake.
Case ascertainment
Incident invasive breast cancer cases were ascertained by self-report and medical record reviews, [16] [17] [18] [19] linkage to cancer registries, 8, [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] or both. 4, [31] [32] [33] Some studies additionally identified cases using linkage to mortality registries. 16, 18, 22, 23, 27, 28, 31 Hormone receptor status was obtained through cancer registries, 8, 20, 23, 25, [27] [28] [29] [30] [31] 33, 34 pathology reports, 16, 18, 24, 26, 32, 34 medical records 4, 17, 19 or laboratory determinations. 22 Cases with borderline hormone receptor status were considered positive for that hormone receptor.
Dietary and non-dietary factors assessment
Dietary intake at baseline was assessed using a food frequency questionnaire (FFQ) or diet history. Each study enquired as to the frequency of consumption of specific alcoholic beverages and the usual number and/or usual consumption of alcoholic drinks consumed on each occasion (Table 1) . We computed total alcohol consumption by summing alcohol intake as grams/day from each alcoholic beverage. All studies assessed folate intake from food (dietary folate). Total folate intake was calculated by summing the folate intake from diet, individual supplements and multivitamins among the 12 studies that assessed use of folate supplements and/or multivitamins. Total folate intake was not available in the Netherlands Cohort Study because multivitamins used in The Netherlands did not include folate when the study was initiated. Folate intake was adjusted for energy intake. 35 The correlation coefficients between intakes estimated from the FFQ or a closely related instrument, and the reference method, generally exceeded 0.7 for alcohol consumption 15 and 0.4 for dietary folate intake across studies. 15 Studies collected non-dietary information including medical history, demographics, lifestyles and menopausal status at baseline. All studies had information on age, height and weight. Most studies had information on reproductive factors, education, physical activity, smoking status and family history of breast cancer.
Statistical analysis
Participants were excluded if they met the exclusion criteria specified within each study, were diagnosed with cancer (except non-melanoma skin cancer) prior to baseline, or reported energy intakes beyond three standard deviations from their study-specific log e -transformed mean energy intake.
The Nurses' Health Study was analysed as two separate cohorts [1980- Alcohol, dietary folate and total folate intakes were categorized using common intake cut-points and/or studyspecific quintiles. We tested for trend from a Wald test using the median intake category as a continuous variable.
Study-specific rate ratios were calculated using Cox proportional hazards regression models separately for overall, ERÀ, ERþ, PRÀ and PRþ breast cancer and tumours defined jointly by ER and PR status; 37 cases without information on hormone receptor status or with a subtype different from the one being evaluated were censored at their diagnosis date. We calculated follow-up time from the baseline questionnaire return date to the date of incident breast cancer diagnosis, death, loss to follow-up or end of the follow-up, whichever came first. Age at baseline and calendar year of questionnaire return were used as stratification variables. In multivariable analyses, we included potential confounders assessed at baseline (see Table 2 ) in the model for studies with ! 200 cases of the outcome being evaluated. Otherwise, we used propensity scores to adjust for confounding. [38] [39] [40] Missing indicators were created for missing responses for each covariate, if applicable.
The study-specific rate ratios were pooled using a random-effects model 41 weighted by the sum of the inverse of the variance and the estimated between-studies variance components. We examined between-studies heterogeneity using the Q statistic. 41, 42 Sources of heterogeneity by region and median follow-up time also were examined. The statistical significance of the differences in the associations by cancer subtype was assessed using the contrast test. 43, 44 We tested whether the association with alcohol intake varied by folate intake, multivitamin use, menopausal status during follow-up (using a previously described algorithm 14 ), hormone-replacement therapy use, family history of breast cancer and smoking status by using a mixed-effects meta-regression model. 15, 45 All statistical tests were two sided.
Results
During 6-18 years of follow-up across 20 prospective cohort studies including 1 089 273 women, 37 191 women were diagnosed with breast cancer including 21 624 ERþ and 5113 ERÀ tumours (Table 1) . Across studies, 11-86% women were drinkers, among whom median alcohol consumption varied 8-fold. Median dietary folate intake varied more than 2-fold across studies. The prevalence of multivitamin use ranged from 3-69% across studies, with higher prevalence observed in the North American studies. We present only the pooled multivariable RRs because the age-adjusted results were similar. Alcohol intake was significantly associated with higher risk of overall, ERþ, ERÀ, PRþ and PRÀ breast cancer ( When we categorized alcohol consumption by 5 g/day increments in an aggregated dataset of all studies, a positive linear trend was observed for alcohol intakes up to 55 g/day, beyond which further increases in risk were not observed but < 1% of women reported alcohol intakes > 55 g/day; Figure 1 ). Therefore, when modeling alcohol consumption as a continuous variable, we restricted analyses to women consuming alcohol less than 55 g/day. The pooled multivariable RRs (95% CI) for alcohol consumption per 10 g/day (approximately 0.75-1 drink/day) were 1.08 (1.07-1.09) for overall breast cancer [P betweenstudies heterogeneity : 0.47]; 1.10 (1.08-1.12) for ERþ breast cancer; and 1.06 (1.02-1.10) for ERÀ breast cancer (P common-effects by ER status: 0.08); 1.10 (1.08-1.12) for PRþ breast cancer; and 1.07 (1.04-1.10) for PRÀ breast cancer (P common-effects by PR status: 0.07).
Alcohol consumption was positively associated with risk of breast cancer defined jointly by ER and PR status. However, only associations for ERþPRþ, ERþPR-, and ERÀPR-were statistically significant; risk estimates were similar across subtypes (Supplementary Table 1, available as Supplementary data at IJE online). Analysing alcohol The Japan Public Health Center-Based Study Cohort I was excluded from this category because there were no cases in this category. The non-cases in the highest category were included in the next highest category.
i
The CLUE 2: Campaign Against Cancer and Heart Disease, Japan Public Health Center-Based Study Cohort I, and Swedish Mammography Cohort were excluded from the highest category because there were no cases in this category. The non-cases in the highest category were included in the next highest category.
intake as a continuous variable yielded similar results (P common-effects by receptor status: > 0.26; data not shown). Alcohol intakes from beer, wine and liquor were each significantly associated with 23-33% higher breast cancer risk comparing ! 15 g/day alcohol consumption from a specific alcohol beverage vs non-drinkers of that beverage. Results did not differ significantly by ER or PR status (P common-effects by ER or PR status for ! 15 g/day category: ! 0.51) (Supplementary Table 2 , available as Supplementary data at IJE online). The results were similar when alcohol intakes from beer, wine and liquor, modelled as continuous variables, were simultaneously included in the multivariable analyses.
The positive association between alcohol consumption and overall breast cancer risk was not modified by total folate intake, multivitamin use, family history of breast cancer, postmenopausal hormone therapy use or smoking status (Table 3) . However, there was a modestly stronger positive association for postmenopausal women compared with premenopausal women (P interaction : 0.04). Associations of alcohol consumption with risk of ERþ and ERÀ breast cancer were not significantly modified by total folate intake, multivitamin use, family history of breast cancer, smoking status or menopausal status (P interaction : ! 0.05; Supplementary Table 3, available as Supplementary data at IJE online). Although there was a stronger positive association for alcohol intake and risk of ERÀ breast cancer among current postmenopausal hormone therapy users than among never and past users (P interaction : 0.01), postmenopausal hormone therapy use did not modify the association between alcohol consumption and risk of ERþ breast cancer (P interaction : 0.76). Similar positive associations between alcohol consumption and risk of PRþ and PRÀ breast cancer were observed across strata of the breast cancer risk factors mentioned above (P interaction : ! 0.17; data not shown), with one exception; the association between alcohol intake and risk of PRþ breast cancer was stronger among women with a family history of breast cancer compared with those without a family history of breast cancer (P interaction : 0.01).
Dietary and total folate intakes were not associated with risk of total, ERþ, ERÀ, PRþ, PRÀ (Table 4) , ERþPRþ, ERþPR-, ERÀPR-or ERÀPRþ breast cancer (Supplementary Table 4 , available as Supplementary data at IJE online). Risk estimates comparing the extreme quintiles of dietary or total folate intake ranged from 0.98 to 1.03 for overall breast cancer and breast cancer subtypes defined by ER and/or PR status (P common-effects for highest quintile: ! 0.32) ( Table 4 ). Restricting analyses of dietary folate intake to participants who had not used supplements containing folic acid or to studies that assessed supplemental folate intake did not change results materially. Separate analyses for studies in North America or for North American studies containing cases diagnosed before mandatory folate fortification of grain products in the USA were almost identical to the main results (data not shown). Analysing dietary and total folate intake as categorical variables using study-specific deciles or common intake The relative risks were adjusted for the covariates listed in footnote 'a' in Table 2.   b The P-value, test for interaction was calculated using meta-regression analyses. For the analyses examining strata defined by menopausal status during follow-up, women were included in the strata of premenopausal women if they were classified as being premenopausal at baseline; these women then contributed person-time to the premenopausal analyses until they turned 51 years old (based on a previously developed algorithm to approximate menopausal status at diagnosis, 14 since follow-up data were not available in several studies), were diagnosed with breast cancer, were lost to follow-up or died, whichever occurred first. Only women who were classified as postmenopausal at baseline were included in the postmenopausal analyses. The Nurses' Health Study II was not included in this stratum because few cases (n < 15) were never users of postmenopausal hormones. The Nurses' Health Study II was not included in this stratum because few cases (n < 15) were past users of postmenopausal hormones. k The CLUE 2: Campaign Against Cancer and Heart Disease and Melbourne Collaborative Cohort Study were not included in this analyses because this variable was not measured. The Japan Public Health Center-Based Study Cohort I was not included in this stratum because few cases (n < 15) had a family history of breast cancer. The Swedish Mammography Cohort was not included in these analyses because this variable was not measured. n The Beta-Carotene and Retinol Efficacy Trial was not included in this stratum because few cases (n < 15) were never smokers. The Japan Public Health Center-Based Study Cohort I was not included in this stratum because few cases (n < 15) were past smokers. cut-points did not substantially change the results for all breast cancer outcomes (data not shown). Excluding cases diagnosed during the first 5 years of follow-up did not alter the results for dietary or total folate intake (data not shown).
Discussion
In this large pooled analysis, total alcohol consumption and alcohol intake from beer, wine and liquor were each positively associated with risk of overall, ERþ, ERÀ, PRþ and PRÀ breast cancer. Associations for breast tumours were not significantly different regardless of ER or PR status. These associations were not modified by total folate intake, multivitamin use, family history of breast cancer, postmenopausal hormone therapy use or smoking status except that a stronger positive association was observed for postmenopausal women compared with premenopausal women. Dietary and total folate intakes were not associated with total or hormone-receptor-defined breast cancer risk.
Our result of a positive association between alcohol consumption and total breast cancer risk is consistent with our previous pooled analyses from six cohort studies 14 and a meta-analysis of 39 cohort studies and 74 case-control studies. 46 Our analyses included four 7, [48] [49] [50] of the six prospective cohort studies 7, 6, 47, [48] [49] [50] that had previously examined associations for specific alcoholic beverages with breast cancer risk. Similar to our results, the two studies 6, 47 not included in our analyses reported positive associations between wine, beer and liquor and breast cancer risk. For breast tumours defined by hormone receptor status, we found associations of similar magnitude for ERþ and ERÀ breast tumours. However, a meta-analysis of three cohort studies (all are included in our analyses) and 16 case-control studies found a slightly stronger association for ERþ [summary RR: 27% (95% CI 17-38%)] compared with ERÀ [summary RR: 14% (95% CI 3-26%)] breast cancer, comparing the highest with lowest alcohol consumption categories. 3 Six subsequent prospective cohort studies have examined associations between alcohol consumption and breast cancer risk defined by hormone receptor status. [4] [5] [6] [7] [8] [9] Of these, only two 5, 6 were not included in our analyses; both of these studies showed statistically significant positive associations with ERþ breast cancer risk 5, 6 but non-significant inverse associations for ERÀ 5 or ERÀPRÀ 6 breast tumours. Our study included all four prospective cohort studies 5, 7, 9, 12 that had previously examined associations between alcohol consumption and breast cancer risk by PR status. Positive associations between alcohol consumption and risk of both ERÀ and ERþ breast cancer are biologically plausible. Alcohol may operate through both hormone-independent and hormone-dependent aetiological pathways. Alcohol increases mammary susceptibility to DNA damage by producing acetaldehyde, which increases oxidative stress and causes epigenetic alterations inhibiting the absorption of methyl donors. 51 In addition, alcohol stimulates cell proliferation by elevating endogenous estrogen levels 52, 53 and promotes breast carcinogenesis.
We observed no change in the alcohol-breast cancer association with high folate consumption. Some, [54] [55] [56] [57] [58] [59] [60] [61] but not all, 4, 7, 50, [62] [63] [64] [65] [66] [67] studies have found that the positive association between alcohol consumption and breast cancer risk was attenuated among women with high folate intake. Only three studies examined whether folate intake modified associations of alcohol consumption with ERÀ and/or ERþ breast cancer risk, 12, 13, 68 all of which were included in our analyses. Similarly, two studies that examined the interaction between folate and alcohol intake and breast cancer risk defined by PR status were included in our analyses. 12, 13 Our observation of no interaction between alcohol and folate intake and breast cancer risk requires cautious interpretation. We could not take into account diet changes over time with baseline dietary intake data; given that the US studies in our analyses started before the mandatory folate fortification of grain products, potential misclassification of folate intake during follow-up might have attenuated the association. 69 Future study with timeintegrated measures of endogenous folate level is warranted. We observed a stronger positive association between alcohol consumption and total breast cancer risk for postmenopausal women than for premenopausal women. Our result is qualitatively similar to our previous analysis 14 and the most recent Nurses' Health Study analysis, with cumulatively updated alcohol intake data over 28 years. 49 The underlying mechanism of this finding is unclear, although associations of breast cancer risk with body mass index 2 and polymorphisms in genes encoding the estrogen receptor and some oxidative enzymes have been found to differ by menopausal status. 70, 71 Alcohol consumption may have a more pronounced effect on breast tissue after menopause. Alternatively, our result may be due to chance. Our study has several strengths. The large number of breast cancer cases allowed us a detailed investigation of associations between alcohol and specific alcoholic beverages and folate intakes and risk of overall and hormonereceptor-defined breast cancer subtypes, and of the interaction between alcohol and folate intake. Median alcohol and folate intake varied more than 2-fold across the studies, minimizing the likelihood of missing an association due to homogeneous dietary habits. Standardizing categorizations for nutrient and covariate data and using similar analytical models across studies reduced heterogeneity among studies. Further, the prospective design of individual studies minimized recall bias.
Our study had limitations. Baseline alcohol or folate intake data may not incorporate possible diet changes during follow-up attenuating associations. However, a US survey found a correlation of 0.63 for alcohol intake collected 10 years apart, suggesting that alcohol consumption at baseline may reasonably represent long-term intake. 72 Baseline folate intake does not take into account mandatory folate fortification of grain products beginning in 1997 in North America; 69 nonetheless, the pooled results from the North American studies for follow-up occurring before folate fortification were similar to those for follow-up occurring after fortification. We could not examine associations at young ages or with the frequency, pattern and duration of alcohol consumption or very high alcohol intakes. Hormone receptor status information was missing for 3-56% of cases across studies, but associations for overall breast cancer were similar for cases with and without hormone receptor data. We could not investigate other tumour subtypes, including HER2 and Ki67, 73 because of a lack of information on these tumor characteristics. Finally, we could not distinguish breast cancers detected by symptoms from those diagnosed by mammography. As tumors detected by mammography, particularly ERþ tumors, 74 are more likely to be indolent, 75 our results for ERþ breast cancer may have been attenuated. In summary, in this large pooled analysis, alcohol consumption was positively associated with risk of breast cancer overall and of subtypes defined by ER and/or PR status. Dietary and total folate intakes were not associated with risk of overall breast cancer or breast cancer subtypes defined by ER and/or PR status. Higher total folate intake did not modify the positive associations between alcohol consumption and risk of overall or hormone-receptordefined breast cancer.
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